Skip to main content

Europe is the Largest Revenue Generation Region for Physiotherapy Equipment Market


The growth of physiotherapy equipment market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease.

Physiotherapy Equipment Market Dynamics: Impact Analysis

1. Increase in The Global Prevalence of Chronic Diseases
2. Growing Incidence of Sports Injuries
3. Emerging Markets
4. Technological Advances
5. Wide Range of Applications

The
physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%.

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global Physiotherapy Equipment market?
2. What are the drivers, restraints, opportunities, and challenges in the Physiotherapy Equipment Industry?
3. What are the
opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Physiotherapy Equipment in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228

Growing Demand for Electrotherapy Equipment:

The electrotherapy equipment segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this segment is mainly driven by the increasing adoption of electric stimulation-based techniques for physiotherapy. Neuromuscular electrical stimulation (NMES), specifically functional electrical stimulation (FES) that compensates for voluntary motion, and therapeutic electrical stimulation (TES) aimed at muscle strengthening and recovery from paralysis are widely used in clinical settings for rehabilitation, especially for stroke.

Musculoskeletal Application:

On the basis of application, the market is segmented into cardiovascular and pulmonary applications, musculoskeletal applications, neurological applications, pediatric applications, gynecological applications, and other applications (includes sports and palliative care). In 2018, the musculoskeletal applications segment accounted for the largest share of the market, followed by the neurological applications segment. The large share of the musculoskeletal applications segment is attributed to the rising incidence of musculoskeletal disorders, growth in the geriatric population, and the increasing number of accidents.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65250228

Europe to Dominate The Industry:

Europe is the major revenue-generating regions in the global physiotherapy equipment industry. Factors such as the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms are driving the growth of the physiotherapy equipment market in Europe.

Key Players:

The major physiotherapy equipment vendors include DJO Global (US), Performance Health (US), BTL Industries (US), and EMS Physio (UK).

DJO Global (US) is a major leader in the physiotherapy equipment market. It maintains its leadership position in this market through its strong distribution network across the globe and with its business operations in the US, the Asia Pacific, the Middle East and Africa, Germany, Australia, Canada, and Latin America.

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...